agilent.com (A) - חוב להון עצמי

Agilent Technologies (A) sets the benchmark for precision in diagnostics and analytics, ensuring product safety and scientific progress. High confidence among scientists in instrument quality is complemented by the modernization of spectrometer manufacturing plants. The total liabilities-to-equity ratio demonstrates the issuer's financial stability, and 0.52 captures the magnitude of this parameter, confirming the company's balanced debt policy.

This metric is calculated as the ratio of total liabilities to equity, measuring the business's degree of dependence on external borrowings. A high ratio signals risks during rate hikes, whereas a low ratio ensures financial stability. For Agilent Technologies (A), the debt balance is critical when developing costly analytical protocols in partnership with pharma behemoths. The company's leverage history allows for an assessment of the financing efficiency of such alliances. This chart helps investors identify a dangerous imbalance in the capital structure in a timely manner.